Intact Vascular gains CE mark for endovascular stapler device; Biomet boosts Q3 sales;

@FierceMedDev: New clues on beating bugs that infect cardiac devices. News  | Follow @FierceMedDev

> Pennsylvania's Intact Vascular gained a CE Mark for its endovascular stapler device, which is used to help improve peripheral angioplasty results. Release

> German medical device and pharmaceutical companies, hospitals and nursing home operators will likely add 70,000 jobs this year, Bloomberg reports, citing a story in the Frankfurter Allgemeine Zeitung. Story

> VertiFlex has gained 5 additional patents covering the design and use of its interspinous space technology. The California company makes minimally invasive spinal surgery implants and other related tech. Release

> Boston Scientific ($BSX) is launching its Z Flex-270 steerable sheath in the U.S., designed for electrophysiology procedures to help place diagnostic and therapeutic catheters in the heart. Release

> eResearch Technology, which provides cardiac safety research for medical device, drug and biopharmaceutical companies, is going private in a $400 million deal, Reuters reports. Story

> Biomet boosted net sales to $709 million in its fiscal 2012 third quarter, the company said, up 5% versus the same period a year ago. The company's sale of sports medicine and extremity-related products grew 22% and 18%, respectively, during the quarter. Release

And Finally... More health industry taxes, anyone? The Institute of Medicine has produced a new report calling for a tax on medical care to drive improvements in the system, The Wall Street Journal's Health Blog reports. Story